Herb Mueller
Analyst · R W. Baird
Thank you, Kate, and good afternoon, everyone. I will start by giving detail on our fiscal second quarter financial results and will then discuss the trends we’re seeing in the third quarter. I’ll also give further detail on the financial impact of our recent acquisitions. Starting with an overview of our second quarter results. Total revenue for the second quarter of fiscal 2019 was $188.8 million, a 20.5% increase from the comparable quarter a year ago. Sequentially, revenue was up 5.7%. On a constant currency basis, revenue increased 21.3% year-over-year and 6% sequentially. Our second quarter gross margin was 38.9%, up 100 basis points from the prior year second quarter, primarily as a result of focus on internal pricing initiatives, as well as lower medical costs. SG&A expenses were $55 million, or 29.1% of revenue, compared to $47.5 million, 30.3% of revenue in the fiscal second quarter a year ago. Our net income improved to $10.6 million, or $0.33 per diluted share, compared to $8.1 million, or $0.27 per diluted share in the prior year quarter. In Q2, adjusted EBITDA was $20 million, or 10.6% of revenue, compared to $13.4 million, or 8.5% of revenue in the year-ago quarter. Now, let me discuss some of the highlights of our revenues geographically. As Kate mentioned, our U.S. performance strengthened in the quarter, with revenue increasing 25% year-over-year, reflecting the Accretive acquisition, as well as estimated organic growth in the 6% to 7% range. We have fully integrated Accretive into our offices, so we can no longer definitively breakout results on a standalone basis. Sequentially, revenue in the U.S. increased 5.4% as a result of the initiatives we have discussed. For the second quarter, total revenues internationally were $39.9 million versus $37.3 million in the second quarter a year ago, an increase of 7% year-over-year, 10.6% constant currency and an increase of 6.9% sequentially, 8.1% constant currency. Europe’s second quarter revenue increased 1% year-over-year and 12% sequentially, 4.2% constant currency year-over-year and 13.1% sequentially. Europe’s growth slowed this quarter from the trend of the last three years, especially in the UK, where economic conditions are mixed bag. The sequential increase was a result of fewer holidays in the second quarter compared to the first quarter. Turning to early revenue trends for the third quarter of fiscal 2018. Weekly revenues in Q3 are trending approximately 6% to 7% ahead of last year. If the current trend continues, revenue would be in the range of $181 million to $186 million. Kate mentioned earlier, we’re seeing some encouraging trends in top line revenue for the quarter ahead. North America is continuing to grow, while Europe and Asia Pac appears stable. North America is strong throughout the geography, especially in Atlanta more than California, Chicago, Dallas, Denver and Mexico City. Tri-State is continuing its transformation. They are focused on getting the right team in place. Revenue was essentially flat year-over-year, however, they were up 3% sequentially in Q2. Financial services revenue is improving, however, much of that additional revenue is occurring outside of the Tri-State area, as they build their operations globally. We are very pleased the turnaround we’re seeing in Southern California. Los Angeles and Orange County combined were up 10.6% year-over-year, 8.4% sequentially. Europe up slightly overall had excellent results in Germany with taskforce leading the way. Asia Pac’s growth is being driven by China. As mentioned above, revenue is trending in the $181 million to $186 million range in the third quarter, compared to $172.4 million a year ago. The high-end of the range is dependent on maintaining the trends we’re currently seeing. Turning to gross margins. Gross margin for the second quarter was 38.9%, increasing 100 basis points from the prior year equivalent period and increasing 70 basis points sequentially. The year-over-year range is related to slightly improved bill pay ratio, driven by internal initiatives to improve pricing, as well as lower medical costs in the quarter. For the second quarter, our gross margin in the U.S. was 39.7%, compared to 39.1% in the second quarter last year and our international gross margin was 35.9%, compared to 34% a year ago. For the third quarter, we expect gross margin to be in the 36.6% to 37.3% range, compared to 36.3% a year ago. The drop sequentially is primarily a result of higher payroll taxes beginning in January. We have been making progress improving bill rates and gross margins in new deals sold. We expect to see the full impact in calendar year 2019. The average hourly bill rate for the quarter was approximately $124, which compares to $124 in the first quarter and $123 in the year-ago quarter. The average pay rate for the second quarter was approximately $62, compared to $63 last quarter and $62 last year. We are having strong growth in lower-cost regions, such as China, India and Latin America that offset some of the bill rate increases that we’re having in other regions. As a reminder, these hourly rates are derived based on prevailing exchange rates during each given period. Now, looking at the components of our second quarter financial results. Selling, general and administrative expenses were $55 million, or 29.1% of revenue. This compares to SG&A of $47.5 million, or 30.3% of revenue in the second quarter of fiscal 2018 and $56.4 million, or 31.6% of revenue in the first quarter of fiscal 2019. The year-over-year percentage decrease from last year’s second quarter relates to improved leverage from revenue growth, with decreases in operating expenses in the quarter somewhat offset by $1 million in severance in quarter two versus $400,000 a year ago. SG&A was down $1.4 million sequentially, resulting from lower benefit expenses in the quarter, primarily payroll taxes and transformation integration costs, offset by increases in severance of $900,000 and the bonus commissions related to revenue growth. Stock compensation expense was $1.7 million, or just under 1% of total revenue. In the third quarter, we expect SG&A to be in the range of $54.5 million to $55 million. Sequentially, severance will be lower, however, we’ll have increased payroll taxes, as well as slightly higher compensation expense. Turning to the other components of our financial statements, depreciation was just under $1.2 million and amortization was just under $1 million. As a result of the improvements noted above, our adjusted EBITDA or cash flow margin, which we defined as EBITDA before stock compensation and contingent consideration adjustments, was 10.6% in the second quarter, up from 8.5% a year ago and 7.4% in the first quarter of fiscal 2019. Our pre-tax income was $15.7 million in the second quarter. During the quarter, we recorded a provision for income taxes of $5.1 million, representing an effective tax rate of 33%. Our GAAP tax rate for each of the upcoming quarters is difficult to predict and could be volatile, as the rate will be dependent on several factors, including the operating results of our U.S. and foreign locations, each of which are taxed or benefited at different statutory rates, and the offset of the tax benefit of foreign losses in certain locations by valuation allowances. On a cash basis, our tax rate was about 31%, and we expect that rate to be in that range going forward. Finally, our GAAP net income was $10.6 million, or $0.33 per share during the second quarter. Now let me turn to the balance sheet. Cash and investments at the end of the second quarter were $40.8 million, a $13.7 million increase in the first quarter of fiscal 2019. Receivables at quarter-end were approximately $146 million, compared to $138 million at the end of the first quarter. Days of revenue outstanding were approximately 64 days, compared to 62 days in the first quarter of fiscal 2019. Dividends for the quarter were approximately $4.1 million. Capital expenditures were $3.4 million during the quarter, as we have multiple office relocations occurring. We are transitioning to an open office footprint requiring new office furniture. We expect CapEx to be in the $5 million to $6 million range in Q3. We are moving three of our largest offices this year, including two of the New York Tri-State – in the New York Tri-State area, as well as our San Francisco office. In the second quarter, we repurchased $5.5 million in stock. Our stock buyback program still has $107 million remaining. Our shares outstanding at the end of the second quarter were approximately $31.7 million. We’ll continue to return cash to shareholders through our quarterly dividend, while balancing debt repayment, the capital requirements are growing our business organically and strategically and fiscal prudence. Now I’d like to turn the call back over to Kate for some closing comments.